34743-49-2

Basic information

• Product Name: 4-methoxy-2,6-dimethyl-aniline
• Synonyms: 4-methoxy-2,6-dimethyl-aniline
• CAS NO: 34743-49-2
• Molecular Formula: C₉H₁₃NO
• Molecular Weight: 151.21
• Mol File: 34743-49-2.mol
• Article Data: 16

Chemical Properties

• Melting Point: 36-37 °C
• Boiling Point: 268.2°Cat760mmHg
• Flash Point: 122°C
• Appearance: /
• Density: 1.019g/cm³
• Vapor Pressure: 0.00779mmHg at 25°C
• Refractive Index: 1.544
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 4.91±0.10(Predicted)
• CAS DataBase Reference: 4-methoxy-2,6-dimethyl-aniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-methoxy-2,6-dimethyl-aniline(34743-49-2)
• EPA Substance Registry System: 4-methoxy-2,6-dimethyl-aniline(34743-49-2)

Safety Data

• Hazardous Substances Data: 34743-49-2(Hazardous Substances Data)

Usage

General Description

4-methoxy-2,6-dimethyl-aniline is a chemical compound with the molecular formula C9H13NO. It is an aromatic amine and aniline derivative, commonly utilized as an intermediate in the synthesis of dyes, pharmaceuticals, and other organic compounds. This chemical is characterized by its methoxy and dimethyl substituents on the aromatic ring, imparting specific physical and chemical properties to the molecule. It is important to handle 4-methoxy-2,6-dimethyl-aniline with caution, as exposure to this compound can cause irritation to the eyes, skin, and respiratory system, and may have potential harmful effects on human health and the environment.

InChI:InChI=1/C9H13NO/c1-6-4-8(11-3)5-7(2)9(6)10/h4-5H,10H2,1-3H3

Upstream product

• 67-56-1 methanol 
• 3096-63-7 N-(2,6-dimethylphenyl)hydroxylamine 
• 61019-03-2 5-methoxy-1,3-dimethyl-2-nitrobenzene 
• 150370-06-2 1-(4-methoxy-2,6-dimethylphenyl)-2-phenyldiazene 
• 37621-81-1 sodium 3,5-dimethylphenolate 
• 77-78-1 dimethyl sulfate 
• 153968-41-3 (4-Methoxy-2,6-dimethyl-benzoyl)-phosphonic acid diethyl ester 
• 7664-93-9 sulfuric acid 
• 37934-89-7 2,6-Dimethyl-4-methoxybenzoic acid 
• 31247-59-3 2,6-dimethyl-4-methoxybenzoyl chloride 
• 1778-71-8 3,5-Dimethyl-4-phenylazo-phenol 
• 5344-97-8 3,5-dimethyl-4-nitrophenol 
• 4102-53-8 4-iodo-2,6-dimethylaniline 
• 3096-70-6 3,5-dimethyl-4-aminophenol 

Downstream Products

• 854053-65-9 2,6-dimethyl-[1,4]benzoquinone-4-(4-methoxy-2,6-dimethyl-phenylimine) 
• 527-61-7 2,6-dimethyl-1,4-benzoquinone 
• 2431-91-6 4-methoxy-2,6-dimethylphenol 
• 391201-50-6 bis-(4-methoxy-2,6-dimethyl-phenyl)-diazene-N,N'-dioxide 
• 111664-97-2 benzenesulfonic acid-(4-methoxy-2,6-dimethyl-anilide) 
• 111065-33-9 3-hydroxy-[2]naphthoic acid-(4-methoxy-2,6-dimethyl-anilide) 
• 32767-54-7 1-(2,6-Dimethyl-4-methoxy-phenyl)-3-phenyl-thioharnstoff 
• 32767-60-5 1-Methyl-3-(2,6-dimethyl-4-methoxy-phenyl)-thioharnstoff 
• 130403-15-5 5-Methyl-isoxazole-3-carboxylic acid (4-methoxy-2,6-dimethyl-phenyl)-amide 
• 37934-89-7 2,6-Dimethyl-4-methoxybenzoic acid 
• 34773-93-8 (4-Methoxy-2,6-dimethyl-phenyl)-thiocarbamic acid O-biphenyl-2-yl ester 
• 31247-59-3 2,6-dimethyl-4-methoxybenzoyl chloride 
• 34751-58-1 C₂₂H₂₁NO₃S 
• 1051398-50-5 N,N'-bis(2,6-dimethyl-4-methoxyphenyl)ethylenediimine 

Relevant articles and documents

B(C6F5)3-Catalyzed C-H Alkylation of N-Alkylamines Using Silicon Enolates without External Oxidant

An efficient method for the coupling of N-alkylamines with silicon enolates to generate β-amino carbonyl compounds is disclosed. These reactions proceed by activation of α-amino C-H bonds by B(C6F5)3, which likely generate

PYRAZOLOPYRIMIDINE DERIVATIVES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTING OR TREATING CANCER, AUTOIMMUNE DISEASE AND BRAIN DISEASE CONTAINING THE SAME AS AN ACTIVE INGREDIENT

The present invention relates to a pyrazolopyrimidine derivative, a preparation method thereof and a pharmaceutical composition comprising the same as an active ingredient for the prevention or treatment of cancer, autoimmune disease and brain disease. The pyrazolopyrimidine derivative of the present invention exhibits excellent Bruton's tyrosine kinase inhibition activity, so that it can be effectively used as a pharmaceutical composition for the prevention or treatment of cancer, autoimmune disease and Parkinson's disease.

Efficient copper-catalyzed amination of DNA-conjugated aryl iodides under mild aqueous conditions

Herein, we describe the development of copper-catalyzed cross-coupling of DNA-conjugated aryl iodides with aliphatic amines. This protocol leverages a novel ligand, 2-((2,6-dimethoxyphenyl)amino)-2-oxoacetic acid, to effect the transformation in aqueous D